Nucleic Acid Testing (NAT) Market to Expand at a CAGR of 7.7% from 2023-2030 | Key Players are Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, Danaher

Nucleic acid testing (NAT) refers to a molecular technique for screening viruses, bacteria or pathogenic nucleic acid in the blood, tissue or urine of the patient. It is conducted for forensic testing and to diagnose transfusion-transmitted infections, genetic diseases and cancer. It involves sample pooling through nucleic acid (NA) extraction, target NA amplification and target amplicon NA detection. The testing involves kits and consumables for performing polymerase chain reaction (PCR), strand displacement amplification (SDA), ligase chain reaction (LCR), transcription-mediated amplification (TMA) and NA sequence-based amplification (NASBA) processes. NAT is also used for the identification of diseases with no visible symptoms and for resolving false reactive interpretations.

Get FREE Sample Report: https://www.delvens.com/get-free-sample/nucleic-acid-testing-market-trends-forecast-till-2030

The global Nucleic Acid Testing (NAT) Market size is projected to reach a CAGR of 7.7% from 2023-2030. Nucleic Acid Testing Market, By Product Type (Nucleic Acid Test Kits (Polymerase Chain Reaction (PCR), Ligase Chain Reaction (LCR), Transcription-mediated Amplification (TMA), Whole Genome Sequencing) and Consumables), By Indication (Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others), By End User (Hospitals & Clinics, Pathology Laboratories, and Academic & Research Organization) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

Rising usage of nucleic acid tests for the treatment of genetically related diseases, cancerous diseases, and infectious diseases caused by bacteria or viruses is anticipated to spur their demand worldwide. Apart from this, extensive use utilized for paternity testing/HLA typing and forensic testing will aid the expansion of the nucleic acid testing market in the coming years. These tests help healthcare professionals and researchers in narrowing down the period of infection. In other words, it reduces the window period between the time of serological detection of a virus and the time of viral exposure. Thus, the ability of these tests to deliver accurate results in the early detection process is likely to accelerate their demand in the forthcoming years.

The inability or difficulty of nucleic acid testing in obtaining quantitative results from a large pool of clinical sample, the difficulty of using the NAT test for susceptibility testing, and the higher cost of nucleic acid testing devices is expected to hamper the growth of the nucleic acid testing market. NAT is a highly sensitive and advanced technique; however, it is associated with high cost and requires dedicated infrastructure facility, equipment, consumables, and technical expertise thus these factors are also hindering the growth of the market.

Top Players covered in Nucleic Acid Testing (NAT) Market report: Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Grifols S.A., Illumina, Inc., Novartis Ag, Qiagen N.V., Quest Diagnostics Incorporated, Siemens Ag, Tecan Group Ltd, Danaher, Thermo Fisher Scientific Inc., Johnson & Johnson Services Inc.

Recent Developments

In December 2021, Roche, a multinational healthcare company based in Switzerland, introduced its latest infectious disease tests on a novel molecular laboratory instrument named cobas 5800 System in countries accepting the CE mark.

11 April 2022 - Abbott, the global healthcare leader, has launched Arachitol Gummie in India, a new fruit-flavoured product for kids and adults. As the body needs vitamin D to absorb calcium for better bone health, keeping recommended levels of vitamin D is essential for overall well-being.

Make an Inquiry Before Buying: https://www.delvens.com/Inquire-before-buying/nucleic-acid-testing-market-trends-forecast-till-2030

Scope of the Report:

Nucleic Acid Testing (NAT) Market is segmented into various segments such as product type, indication, end user and region:

On the basis of product type, the Nucleic Acid Testing (NAT) Market Segmented into:

Nucleic Acid Test Kits
Consumables

On the basis of the indication, the Nucleic Acid Testing (NAT) Market Segmented into:

Infectious Disease
Cancer
Forensic Testing
Personalized Medicine
Others

On the basis of end-use, the Nucleic Acid Testing (NAT) Market Segmented into:

Hospitals & Clinics
Pathology Laboratories
Academic & Research Organization

On the basis of region, the Nucleic Acid Testing (NAT) Market Segmented into:

Asia Pacific
North America
Europe
South America
Middle East & Africa

North America to Dominate the Market

North America holds a dominant position in the nucleic acid testing market. This is owing to increasing research and development studies by various government and pharmaceutical organizations in infectious disease and cancer diagnosis in North America.

Furthermore, high prevalence and awareness of cancer among people, in turn opting for early detection of cancer, is expected to aid in the growth of the nucleic acid testing market in this region.

The Nucleic Acid Testing (NAT) market is experiencing significant growth and is expected to continue its upward trajectory in the foreseeable future. The increasing demand for accurate and reliable diagnostic testing for infectious diseases, genetic disorders, and cancer has driven the adoption of NAT technologies. The advancements in molecular diagnostics, along with the development of automated systems and high-throughput testing platforms, have further propelled the growth of the NAT market.

NAT has emerged as a powerful tool in the field of diagnostics, offering advantages such as high sensitivity, specificity, and rapid results. It has played a pivotal role in the detection and management of infectious diseases, including HIV, hepatitis, and COVID-19, facilitating early diagnosis and treatment initiation. Moreover, the growing focus on personalized medicine and precision diagnostics has expanded the application of NAT in genetic testing for inherited diseases, pharmacogenomics, and prenatal screening, among others.

Direct Purchase of the Nucleic Acid Testing (NAT) Market Research Report at: https://www.delvens.com/checkout/nucleic-acid-testing-market-trends-forecast-till-2030

Contact Us:

UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
SALES@DELVENS.COM
WEBSITE: https://delvens.com/

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

This release was published on openPR.